MedPath

The effect of four flower herbal vaginal gel and auricular therapy on atrophic vaginitis

Phase 2
Recruiting
Conditions
Volvovaginal atrophy.
Postmenopausal atrophic vaginitis
N95.2
Registration Number
IRCT20211013052757N1
Lead Sponsor
Esfahan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
90
Inclusion Criteria

Age: 45 to 65 years old
12 months have passed since menopause
Symptoms of vaginal atrophy
Patient consent to participate in the project
Being married
Natural Pap smear in the past year

Exclusion Criteria

Breast or uterine cancer
Abnormal vaginal bleeding
Vaginal device abnormalities
Taking oral hormonal medication 8 weeks before treatment
Use of topical hormonal creams or topical lubricants in the last month

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Volvaginal Atrophy Mental Symptoms. Timepoint: Completion of Volvaginal Atrophy Mental Symptoms Questionnaire before intervention, end of week 4 and end of week 8 after intervention. Method of measurement: Volvaginal Atrophy Mental Symptoms Questionnaire.;Women's sexual function index. Timepoint: Completion of women's sexual function index questionnaire before the intervention, end of week 4 and end of week 8 after the intervention. Method of measurement: Women's sexual function index questionnaire.;Quality of life for postmenopausal women. Timepoint: Completion of quality of life evaluation questionnaire for postmenopausal women before the intervention, end of week 4 and end of week 8 after the intervention. Method of measurement: Quality of life evaluation questionnaire for postmenopausal women.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath